First American Trust’s Gilead Sciences GILD Stock Holding History

First American Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Sell	2,018 -54	-3%	-$7.12K	0.02%	264
2026 Q1	$289K	Buy	2,072 +64	+3%	+$8.96K	0.02%	239
2025 Q4	$246K	Buy	2,008 +193	+11%	+$23.5K	0.02%	249
2025 Q3	$201K	Buy	+1,815	New	+$206K	0.01%	243
2020 Q4	–	Sell	-3,627	Closed	-$229K	–	156
2020 Q3	$229K	Sell	3,627 -36,870	-91%	-$2.56M	0.04%	128
2020 Q2	$3.12M	Buy	40,497 +3,179	+9%	+$244K	0.61%	62
2020 Q1	$2.79M	Buy	+37,318	New	+$2.58M	0.68%	54
2016 Q4	–	Sell	-3,276	Closed	-$259K	–	112
2016 Q3	$259K	Sell	3,276 -27,156	-89%	-$2.21M	0.08%	98
2016 Q2	$2.54M	Sell	30,432 -2,500	-8%	-$222K	0.9%	51
2016 Q1	$3.02M	Sell	32,932 -10,639	-24%	-$959K	1.06%	44
2015 Q4	$4.41M	Buy	43,571 +548	+1%	+$57K	1.62%	24
2015 Q3	$4.22M	Sell	43,023 -304	-0.7%	-$33.8K	1.63%	21
2015 Q2	$5.07M	Sell	43,327 -2,213	-5%	-$242K	1.88%	15
2015 Q1	$4.47M	Buy	45,540 +22	+0%	+$2.23K	1.59%	23
2014 Q4	$4.29M	Sell	45,518 -2,525	-5%	-$261K	1.59%	23
2014 Q3	$5.11M	Sell	48,043 -10,009	-17%	-$980K	1.9%	12
2014 Q2	$4.81M	Sell	58,052 -66	-0.1%	-$5.14K	1.83%	15
2014 Q1	$4.12M	Sell	58,118 -568	-1%	-$44.5K	1.54%	24
2013 Q4	$4.41M	Sell	58,686 -9,534	-14%	-$664K	1.49%	20
2013 Q3	$4.29M	Buy	68,220 +18,498	+37%	+$1.11M	1.54%	21
2013 Q2	$2.55M	Buy	+49,722	New	+$2.59M	0.96%	43

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First American Trust's GILD Position: Q2 2026 in Review

First American Trust reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $7.12K and leaving 2,018 shares worth $255K. The position accounts for 0.02% of the portfolio, ranked #264.

First American Trust first reported a position in GILD in Q2 2013 and has held it in 21 quarters since. The position peaked at $5.11M in Q3 2014. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

First American Trust held 2,018 shares of Gilead Sciences worth $255K as of Q2 2026.
First American Trust sold 54 Gilead Sciences shares in Q2 2026, an estimated $7.12K.
Gilead Sciences made up 0.02% of First American Trust's portfolio in Q2 2026, its #264 holding.
First American Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 21 quarters since.
First American Trust's Gilead Sciences position peaked at $5.11M in Q3 2014.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First American Trust's 13F filing for Q2 2026, filed 10 Aug 2026.